Regardless of the ongoing debates surrounding academic consensus and clinical implementation, there is universal agreement on the critical importance of early sepsis identification.
Data analytics can be the difference between mere treatment of sepsis and active improvement of sepsis survival rates.
Sepsis has persistently remained one of the leading causes of death despite centuries of scientific advancements and a deeper understanding of its pathophysiology. One study found that more than half of hospitalized patients who had died or were discharged to hospice had sepsis, leading to mortality in more than a third of the cohort. Regardless of its incidence and despite significant progress in modern medicine — the mortality rate associated with sepsis has remained alarmingly high, with the main mitigating factor being issues with early diagnosis and a standardized approach to therapy.
In this sense, beyond standardized treatment protocols — such as the widely adopted sepsis bundle — early recognition has become key to enhancing outcomes and reducing mortality.
Sepsis, particularly in its early stages or among infants and older adults, often manifests with subtle and nonspecific signs and symptoms, but substantial efforts have been dedicated to developing clinical decision-support tools and early warning systems. A recent trial demonstrated that the relative risk of mortality was 15% lower in patients who were electronically screened through a sepsis alert system.
The grim prognosis of sepsis extends beyond acute-term mortality. Patients who survive an initial episode frequently experience significantly lower quality of life compared to non-septic ICU admissions and face an increased risk of admission to a long-term care (LTC) facility for at least a year post-discharge and a 50% mortality within 2 years of admission. Early diagnosis remains the best approach to sepsis.
Table of Contents
Sepsis Diagnosis
Sepsis is not a uniform diagnosis but rather a condition that exists on a spectrum, ranging from localized infection and bacteremia to multiple organ dysfunction and, ultimately, death. Over the past several decades, its definitions and clinical presentations have rapidly evolved. Notably, systemic inflammatory response syndrome (SIRS), which was once considered part of the sepsis spectrum, is no longer included in official sepsis definitions. However, despite this shift, the Centers for Medicare and Medicaid Services (CMS) continues to recognize SIRS, sepsis, and severe sepsis as valid diagnostic categories.
The most commonly accepted consensus definition of sepsis as a “life-threatening organ dysfunction caused by a dysregulated host response to an infection” was formally issued by the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) through their joint task force under the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Unlike earlier definitions, Sepsis-3 has shifted the focus to organ dysfunction, assessed by the Sequential (or Sepsis-related) Organ Failure Assessment (SOFA) score or the quick (q)SOFA score, rendering the term “severe sepsis” redundant, as organ dysfunction is now inherently part of the definition of sepsis itself.
Furthermore, Sepsis-3 has redefined septic shock as a distinct subset of sepsis, characterized by the presence of persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) of ≥65 mmHg and a serum lactate concentration exceeding 2 mmol/L (>18 mg/dL).
Need for Early Sepsis Identification
Regardless of the ongoing debates surrounding academic consensus and clinical implementation, there is universal agreement on the critical importance of early sepsis identification. Since sepsis often presents with nonspecific, nonlocalized, or nonclassical symptoms — such as hypothermia rather than fever in response to infections — early diagnosis hinges on maintaining a high index of suspicion. Different diagnostic criteria, definitions, and patient comorbidities all add to the confusion of diagnosis but should not detract from the clinician’s diligence in recognizing sepsis, particularly in high-risk populations such as neonates, the elderly, immunocompromised individuals, diabetics, those with a history of IV drug use, and those with invasive devices, including IV lines and urinary catheters.
Further, the evidence doesn’t support the ongoing argument that sepsis overdiagnosis may be as detrimental as underdiagnosis due to concerns over antibiotics overuse or fluid overload in susceptible patients. While antibiotic stewardship is undoubtedly critical, the potential consequences of missing sepsis far outweigh a cautious approach. As such it is better to err on the side of overdiagnosis.
Historical Data in Managing Sepsis
Considering the diagnostic uncertainties surrounding sepsis, one indisputable truth remains: Early diagnosis and clinical decision support are essential to improving patient outcomes and lowering mortality rates. Clinical vigilance should be supplemented by access to robust, high-resolution historical data that can allow hospitals and clinicians on the front lines alike to identify patterns, refine protocols, and ensure consistency in sepsis management. This is precisely where d2i’s Emergency Medicine Performance Analytics offers a transformative advantage.
Risk factors for sepsis are the fifth leading cause of years of productive life lost due to premature mortality, making identification of high-risk patients imperative. While classical risk factors such as advanced age or bacteremia can easily be deduced by a clinician, less subtle risk factors such as previous hospitalization or a history of malignancy can be obscured and in a busy ED environment be overlooked, necessitating a broader overview and approach.
d2i’s fit-for-purpose data can give hospitals the ability to analyze historical trends and pinpoint patient groups that have the greatest likelihood of poor long-term outcomes from sepsis. By examining granular, site-specific data, d2i enables hospitals to proactively refine sepsis protocols, ensuring early intervention for vulnerable patients such as cancer patients, individuals with dementia, diabetics, and those with chronic renal or hepatic conditions, all of whom have significant mortality and morbidity burden following sepsis.
By leveraging d2i’s platform based on historical data, hospitals can identify commonalities among patients who have suffered high-mortality sepsis episodes, allowing them to implement early-warning systems or allocate resources more efficiently for these at-risk groups. This data-driven approach can then ensure that early recognition strategies are tailored to the unique patient population of each facility, rather than relying on generalized, one-size-fits-all protocols.
Tailoring Sepsis Approach
One of the persistent challenges in sepsis care is protocol variability across healthcare settings, with data demonstrating that higher levels of care are associated with enhanced protocol adherence and outcomes. Hospitals often struggle with adherence to standardized sepsis bundles due to inconsistencies in how diagnostic criteria are applied or variations in response protocols between units. d2i’s analytics can provide insight into protocol adherence across multiple sites, allowing hospitals to:
- Track compliance with early recognition protocols.
- Compare intervention strategies across different emergency departments and ICUs.
- Standardize diagnostic criteria usage, reducing the risk of misclassification or under-recognition of sepsis, as well as ensuring accurate reporting within the context of value-based healthcare and quality metrics, potentially enhancing the bottom line.
One of the most impactful aspects of d2i is its ability to break down treatment variation by physician. This granular level of analysis allows hospitals to identify individual practice patterns and understand how they contribute to overall sepsis care quality. Analyzing physician-level data can reveal variations in adherence to sepsis bundles, time to antibiotic administration, and other critical interventions. By identifying and addressing these variations, hospitals can standardize best practices, reduce unwarranted variation in care, and improve patient outcomes.
By bridging the gap between retrospective analytics and future predictive capabilities, d2i provides hospitals with a data foundation to support AI-driven clinical decision-making, ensuring that sepsis response strategies are not only reactive but also proactively designed for long-term improvement, with high-quality evidence demonstrating such an approach is mainly dependent on the quality of the data, where d2i excels.
Discover how d2i can help your hospital enhance sepsis identification, standardize care protocols, and improve long-term patient outcomes. Contact d2i or book a meeting to explore how our data-driven solutions can transform your sepsis management strategies.